June 2023
Volume 64, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2023
Hydrogel Expansion of the Suprachoroidal Space Lowers IOP in Rabbit and Monkey Eyes
Author Affiliations & Notes
  • Yooree Grace Chung
    Emory University School of Medicine, Atlanta, Georgia, United States
    Georgia Institute of Technology Wallace H Coulter Department of Biomedical Engineering, Atlanta, Georgia, United States
  • Carol B Toris
    The Ohio State University Wexner Medical Center, Columbus, Ohio, United States
  • Vikas Gulati
    University of Nebraska Medical Center, Omaha, Nebraska, United States
  • Shan Fan
    University of Nebraska Medical Center, Omaha, Nebraska, United States
  • Mark Prausnitz
    Chemical & Biomolecular Engineering, Georgia Institute of Technology, Atlanta, Georgia, United States
  • C Ross Ethier
    Georgia Institute of Technology Wallace H Coulter Department of Biomedical Engineering, Atlanta, Georgia, United States
  • Footnotes
    Commercial Relationships   Yooree Chung None; Carol Toris None; Vikas Gulati None; Shan Fan None; Mark Prausnitz Clearside Biomedical, Inc., Code I (Personal Financial Interest), WO2021231977A1, Code P (Patent); C Ross Ethier Pending, Code P (Patent)
  • Footnotes
    Support  Georgia Research Alliance, NEI T32 Vision Training Grant
Investigative Ophthalmology & Visual Science June 2023, Vol.64, 3475. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Yooree Grace Chung, Carol B Toris, Vikas Gulati, Shan Fan, Mark Prausnitz, C Ross Ethier; Hydrogel Expansion of the Suprachoroidal Space Lowers IOP in Rabbit and Monkey Eyes. Invest. Ophthalmol. Vis. Sci. 2023;64(8):3475.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Suprachoroidal space (SCS) expansion via microneedle (MN) using a single injection of an inert hydrogel reduces intraocular pressure (IOP) in ocular normotensive (NT) rabbits. This is a novel, potential treatment for glaucoma (Chae at al., Adv Sci, 2021). Here we examined the effect of repeat injections on IOP in rabbits and single injections on IOP in NT and ocular hypertensive (HT) cynomolgus monkeys.

Methods : NT New Zealand White rabbits received two SCS injections in the same eye at least 6 months apart (n=2). Cynomolgus monkeys received single MN hydrogel injections in NT (n=7) and HT eyes (n=6); controls received sham saline MN injections (n=2 NT, n=3 HT). Hydrogels were based on hyaluronic acid or other materials, with injection volumes of 50 µl (rabbits, HT monkeys) or 100 µl (NT monkeys). IOP and eye wall thickness (EWT), a measure of SCS expansion, were monitored by tonometry and ultrasonography.

Results : After single and repeat injections in rabbits, IOP initially dropped by ~4 mmHg, while EWT correspondingly increased by ~2-3 mm, both returning to baseline over 2-3 months (Fig. 1). The second injection had a similar effect on IOP as the first since regression fits to single and repeat injections were not statistically different (p=0.41). Similar effects on IOP were seen in monkeys, but with faster kinetics (Fig. 2). In NT and HT eyes, IOP initially dropped by ~8 and 15 mmHg and was reduced for 38.8 [33.2, 44.4] and 42.7 [29.6, 55.9] days, respectively, and hydrogel injections had a different effect on IOP compared to sham (saline) injections since individual regression fits differed (p<0.0001). In HT and NT eyes, EWT increased by ~2-3 mm and then gradually decreased for 1-2 months.

Conclusions : A second SCS hydrogel injection was as effective at IOP lowering as the first. IOP reduction via SCS hydrogel injection occurred in both monkeys and rabbits; however, the duration of IOP lowering was shorter in monkeys. Further formulation optimization is ongoing to extend the IOP lowering effect.

This abstract was presented at the 2023 ARVO Annual Meeting, held in New Orleans, LA, April 23-27, 2023.

 

Figure 1: Delta IOP (circles, left axis) and Delta EWT (square, right axis) after first (red) and second (blue) injections in the same eye vs. time. Delta values are compared to baseline (before injection).

Figure 1: Delta IOP (circles, left axis) and Delta EWT (square, right axis) after first (red) and second (blue) injections in the same eye vs. time. Delta values are compared to baseline (before injection).

 

Figure 2: Delta IOP (circles, left axis) after injection in (A) HT and (B) NT monkey eyes with sham (green) and hydrogel (black) vs. time. Delta EWT of eyes with hydrogel injection (squares) shown on right axis.

Figure 2: Delta IOP (circles, left axis) after injection in (A) HT and (B) NT monkey eyes with sham (green) and hydrogel (black) vs. time. Delta EWT of eyes with hydrogel injection (squares) shown on right axis.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×